Nanolife

Licensed Proprietry Technology from the University of Missouri, U.S.A. NanOlife is the first company in the world to embrace the highly sophisticated scientific concept of applying Green Nanotechnology to develop Nanomedicine products within the Oncology, Ophthalmology, Antibiotics and Cosmeceuticals space. It all started through Professor Kattesh Katti’s over three decades of research in biomedical sciences. In 2005, National Cancer Institute of the National Institutes of Health of USA invested in Professor Katti’s Nanomedicine Research at the University of Missouri, USA. This investment helped Professor Katti to invent the concept of Green Nanotechnology which allows the application of disease curing phytochemicals to develop varieties of gold and silver nanoparticles for use in cancer therapy, ophthalmology, antibiotics and allied medical applications.